TCF12 and cancer: Motif analysis revealed the presence of a TCF12-binding site within this hypoDMR and chromatin immunoprecipitation sequencing (ChIP-seq) data in a cancer cell line (A549) supported strong binding of TCF12 in this enhancer region.